Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial.
Authors: Skeith L; Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: laskeith@ucalgary.ca., Malinowski AK; Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Lunenfeld-Tanenbaum Research Institute, Sinai Health, University of Toronto, Toronto, ON, Canada., El-Chaâr D; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada., Chan WS; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Donnelly J; Rotunda Hospital, Dublin, Ireland; Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland; School of Medicine, University of College Dublin, Dublin, Ireland., Chauleur C; Department of Obstetrics and Gynecology, Université Jean Monnet Saint-Étienne, University Hospital, INSERM, SAINBOISE U1059, Saint-Étienne, France., Ganzevoort W; Department of Obstetrics and Gynaecology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands; Amsterdam Reproduction and Development Research Institute, Amsterdam, Netherlands., Wood S; Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada., Dubois S; CanVECTOR Research Network, The Ottawa Hospital, Ottawa, ON, Canada., McCarthy C; Department of Obstetrics and Gynecology, Cork University Maternity Hospital, Cork, Ireland., Buchmuller A; Centre d'Investigation Clinique 1408, INSERM, Centre Hospitalier Universitaire, Saint-Étienne, France., Wiegers H; Department of Obstetrics and Gynaecology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Gibson PS; Department of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada., Ní Áinle F; Department of Obstetrics and Gynaecology, Royal College of Surgeons in Ireland, Dublin, Ireland; School of Medicine, University of College Dublin, Dublin, Ireland., Middeldorp S; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands., Duffett L; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Bates SM; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada., Garven A; Faculty of Nursing, University of Alberta, AB, Canada., Baxter J; Division of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada., Lethebe BC; Clinical Research Unit, University of Calgary, Calgary, AB, Canada., Rodger MA; Department of Medicine, McGill University, Montreal, QC, Canada.
Corporate Authors: Pilot PARTUM Group
Source: The Lancet. Haematology [Lancet Haematol] 2025 Feb; Vol. 12 (2), pp. e109-e119. Date of Electronic Publication: 2025 Jan 16.
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3026
DOI:10.1016/S2352-3026(24)00338-7